Global Medical REIT Inc. (GMRE)
9.06
0.26 (2.95%)
At close: Mar 03, 2025, 3:59 PM
8.96
-1.16%
After-hours: Mar 03, 2025, 05:41 PM EST
Global Medical REIT Income Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | 138.78M | 140.93M | 137.28M | 115.94M | 93.73M | 70.73M | 53.19M | 30.22M | 8.08M | 2.06M | 380.4K | n/a | n/a |
Cost of Revenue | 155K | 86.22M | 25.19M | 15.49M | 10.87M | 5.96M | 3.72M | 1.86M | 1.43M | 1.02M | 360K | n/a | n/a |
Gross Profit | 138.63M | 54.72M | 112.09M | 100.45M | 82.86M | 64.77M | 49.47M | 28.36M | 6.65M | 1.04M | 20.41K | n/a | n/a |
Operating Income | 109.53M | 37.94M | 38.83M | 37.12M | 16.55M | 27.33M | 22.24M | 7.35M | -2.21M | -1.52M | -652.21K | -45.34K | -50.11K |
Interest Income | n/a | n/a | 25.23M | 19.7M | 18.68M | 17.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 811K | 21.73M | 20M | 18.34M | -2.5M | 9.59M | 14.56M | -87K | -6.35M | -1.61M | -652.21K | -45.34K | -50.11K |
Net Income | 811K | 20.61M | -5.23M | -2.07M | -20.61M | -8.24M | 13.49M | -38K | -6.35M | -1.61M | -652.21K | -45.34K | -50.11K |
Selling & General & Admin | 21.12M | 16.85M | 16.55M | 16.45M | 29.96M | 12.8M | 9.96M | 8.61M | 5.73M | 865.14K | 604.87K | 45.34K | 50.11K |
Research & Development | n/a | n/a | 0.15 | 0.17 | -0.03 | 0.14 | 0.27 | -0.00 | -0.77 | n/a | n/a | n/a | n/a |
Other Expenses | 7.97M | n/a | 56.72M | 46.88M | 36.35M | 24.64M | 17.27M | 121K | 130.78K | 659.67K | 129.08K | n/a | n/a |
Operating Expenses | 29.1M | 16.9M | 73.27M | 63.33M | 66.32M | 37.44M | 27.23M | 18.61M | 8.1M | 1.52M | 733.95K | 45.34K | 50.11K |
Interest Expense | 28.69M | 30.89M | 25.23M | 19.7M | 18.68M | 17.47M | 14.97M | 7.43M | 4.14M | 1.52M | 298.66K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 29.25M | 103.11M | 98.46M | 78.82M | 77.18M | 43.4M | 30.95M | 20.47M | 8.1M | 1.52M | 733.95K | 45.34K | 50.11K |
Income Tax | n/a | n/a | 25.23M | 20.42M | 18.11M | 17.83M | 1.07M | -49K | 4.27M | 1.52M | 597.33K | n/a | 50.11K |
Shares Outstanding (Basic) | 65.94M | 65.55M | 65.46M | 60.64M | 46.26M | 33.87M | 21.97M | 19.62M | 9.3M | 250K | 48.36K | 19.57K | 20K |
Shares Outstanding (Diluted) | 65.94M | 65.55M | 65.46M | 60.64M | 46.26M | 33.87M | 21.97M | 19.62M | 9.3M | 250K | 48.36K | 19.57K | 20K |
EPS (Basic) | 0.01 | 0.23 | -0.08 | -0.03 | -0.45 | -0.24 | 0.61 | -0.00 | -0.68 | -6.44 | -13.49 | -2.32 | -2.51 |
EPS (Diluted) | 0.01 | 0.23 | -0.08 | -0.03 | -0.45 | -0.24 | 0.61 | -0.00 | -0.68 | -6.44 | -13.49 | -2.32 | -2.51 |
EBITDA | 109.53M | 111.67M | 96.49M | 84M | 53M | 50.82M | 40.2M | 17.35M | 2.48M | 569.53K | -224.46K | -45.34K | n/a |
Depreciation & Amortization | n/a | 59.01M | 98.81M | 78.97M | 77.51M | 43.7M | 31.33M | 23M | 10.43M | 659.67K | 129.08K | n/a | 50.11K |